June 24, 2020
SDS Rx enters the radiopharmaceutical transport market
Today, SDS Rx announces the acquisition of Medical Delivery Services Inc (MDS). The acquisition will provide SDS Rx an immediate, dominant position in the transport of last mile Radiopharmaceuticals. MDS, with a national footprint, provides safe and reliable nuclear medicine transport.
“This acquisition is a perfect fit as we execute on our strategic growth initiative to grow complementary segments of the healthcare market. The radiopharmaceutical market, is a large unique market that requires years of experience to service. MDS brings the people, the experience and the reputation which will allow us to continue to grow our market share in this important segment”, said Drew Kronick, CEO of SDS Rx.
Chuck Pasquotto, President of MDS commented, “ we are really enthusiastic about partnering with Drew and the SDS Rx team. We believe that together we will be able to provide a multi faceted service offering by accelerating technology and service enhancements to our radiopharmaceutical clients and market we serve.”
About SDS Rx
SDS Rx provides dedicated, flexible delivery solutions nationwide to long term care, specialty, infusion, as well as pharmaceutical distributors, labs and healthcare networks. Our industry-leading technology is seamlessly integrated with each unique customer in order to ensure compliance, accuracy, accountability and transparency.
About Medical Delivery Services
MDS was established in 1977 to service the radiopharmaceutical industry. Through superior Commitment, Service and Compliance, MDS is a nationwide specialized carrier for the legal and safe transportation of radiopharmaceuticals for all major Nuclear Medicine manufactures and shippers.